These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 8829954)
21. Can we cause regression of coronary atherosclerosis? Alsafwah S; Ramanathan KB Am J Med Sci; 2008 May; 335(5):368-74. PubMed ID: 18480653 [TBL] [Abstract][Full Text] [Related]
22. [Regression of coronary atherosclerosis evaluated by angiography. A review of principal trials and critical study]. Castaigne A; Albo C; Pham I; Saal JP; Verschuren P Arch Mal Coeur Vaiss; 1993 Jan; 86 Spec No 1():31-7. PubMed ID: 8215778 [TBL] [Abstract][Full Text] [Related]
27. Effects of long term cholesterol lowering on coronary atherosclerosis in patient risk factor subgroups: the Simvastatin/enalapril Coronary Atherosclerosis Trial (SCAT). Burton JR; Teo KK; Buller CE; Plante S; Catellier D; Tymchak W; Taylor D; Dzavik V; Montague TJ; Can J Cardiol; 2003 Apr; 19(5):487-91. PubMed ID: 12717482 [TBL] [Abstract][Full Text] [Related]
28. [Lipid factors and evolution of the atherosclerotic plaque: review of recent trials]. Scardi S G Ital Cardiol; 1996 Dec; 26(12):1481-93. PubMed ID: 9162677 [TBL] [Abstract][Full Text] [Related]
29. Limitations of angiography for analyzing coronary atherosclerosis progression or regression. Hong MK; Mintz GS; Popma JJ; Kent KM; Pichard AD; Satler LF; Leon MB Ann Intern Med; 1994 Sep; 121(5):348-54. PubMed ID: 8042825 [TBL] [Abstract][Full Text] [Related]
30. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update. Hartmann M; Huisman J; Böse D; Jensen LO; Schoenhagen P; Mintz GS; Erbel R; von Birgelen C Eur J Echocardiogr; 2011 Apr; 12(4):313-21. PubMed ID: 21421584 [TBL] [Abstract][Full Text] [Related]
31. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. Hodis HN; Mack WJ; LaBree L; Cashin-Hemphill L; Sevanian A; Johnson R; Azen SP JAMA; 1995 Jun; 273(23):1849-54. PubMed ID: 7776501 [TBL] [Abstract][Full Text] [Related]
32. Clinical trial endpoints: angiograms, events, and plaque instability. Ballantyne CM Am J Cardiol; 1998 Sep; 82(6A):5M-11M. PubMed ID: 9766342 [TBL] [Abstract][Full Text] [Related]
33. Pixel or death: experience from clinical trials assessing lipid lowering therapy. Barth JD Can J Cardiol; 1995 May; 11 Suppl C():9C-14C. PubMed ID: 7750051 [TBL] [Abstract][Full Text] [Related]
34. Women in the POSCH trial. Effects of aggressive cholesterol modification in women with coronary heart disease. The POSCH Group. Program on the Surgical Control of the Hyperlipidemias. Buchwald H; Campos CT; Matts JP; Fitch LL; Long JM; Varco RL Ann Surg; 1992 Oct; 216(4):389-98; discussion 398-400. PubMed ID: 1417188 [TBL] [Abstract][Full Text] [Related]
36. Evolution of coronary atherosclerosis in patients with mild coronary artery disease studied by serial quantitative coronary angiography at 2 and 4 years follow-up. The Multicenter Anti-Atheroma Study (MAAS) Investigators. Vos J; de Feyter PJ; Kingma JH; Emanuelsson H; Legrand V; Winkelmann B; Dumont JM; Simoons LM Eur Heart J; 1997 Jul; 18(7):1081-9. PubMed ID: 9243140 [TBL] [Abstract][Full Text] [Related]
37. Regression of coronary atherosclerosis by simvastatin: a serial intravascular ultrasound study. Jensen LO; Thayssen P; Pedersen KE; Stender S; Haghfelt T Circulation; 2004 Jul; 110(3):265-70. PubMed ID: 15238460 [TBL] [Abstract][Full Text] [Related]
38. [Can the progression of coronary heart disease be modified by calcium antagonists?]. Schneider W; Roebruck P; Kober G; Alle M; Cieslinski G; Mildenberger D; Satter P; Kaltenbach M Z Kardiol; 1989; 78 Suppl 5():112-20. PubMed ID: 2698562 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of two lipid-lowering treatments on quantitative coronary angiographic endpoints. Mack WJ; Xiang M; Shircore AM; Selzer RH; Hodis HN; Azen SP Cardiovasc Drugs Ther; 2000 Aug; 14(4):411-8. PubMed ID: 10999648 [TBL] [Abstract][Full Text] [Related]